Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in U.S. market

Mar 17, 2022

Wall (South Dakota)/Atlanta [US]/Ahmedabad (Gujarat) [India], March 17 (ANI/PR Newswire): Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. today announced the launch of Butalbital, Acetaminophen...